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1
Introduction
Background
In the United States alone, more than one million people are blind (1).
More than 3.4 million people age forty and over are visually impaired, and over
11 million individuals age 12 and older suffer from visual impairments (2). More
than 14 million people in the U.S. and 135 million worldwide have low vision
(3).
The leading causes of these sight-threatening diseases are Diabetic
Retinopathy, Age-related Muscular Degeneration (AMD), Retinitis Pigmentosa
and Glaucoma (4). Diabetic Retinopathy is caused by damage of blood vessels of
the retina and is the leading cause of blindness in working age Americans,
affecting more than 5.3 million Americans above the age of 18 (4). Age- related
Muscular Degeneration is a condition that primarily affects the part of the retina
responsible for sharp central vision. AMD is the most common cause of legal
blindness and vision impairments in older Americans, plaguing about 1.6 million
Americans over the age of 60 (4). Glaucoma is a chronic condition marked by
gradual damage to the optic nerve that carries visual information from the eye to
the brain (4). Retinitis Pigmentosa results from the death of photoreceptor cells,
which leads to the decline of vision (4). All of these diseases result from the death
of one or more retinal cell type. Currently, there is no cure for blinding diseases
caused by retina cell death.
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The Vertebrate Retina
The vertebrate retina is the light sensitive tissue lining the inner surface of
the eye. The retina receives image seen through the eye and it is responsible for
transmitting this information through optical nerves to the brain (5). The retina is
comprised of many cells, including the two types of photoreceptors, rods and
cones. Rods are very sensitive to low light conditions and able to respond to a
single photon of light; they are responsible for vision under low light conditions
and also periphery vision. Rods are concentrated on the outer edges of the retina,
and on average there are about 90 million rods in the retina (7). On the other hand,
cones require more light for functioning and they provide information about color
in very sharp detail. Cone cells are concentrated around the retina’s center. On
average there are about 4.5 million cone cells in the retina. In humans, it is known
that the loss of rod photoreceptors leads to degeneration of cones, and one of the
commonly known disease in which this concept is manifested is Retinitis
Pigmentosa. Approximately 100,000 people in the United States and 1.5 people
worldwide are affected by Retinitis Pigmentosa, and there is no cure.
Retinitis pigmentosa (RP) is a heterogeneous group of inherited disorders
characterized by the initial loss of rod photoreceptors (7). Since rod
photoreceptors are finely tuned to detect low-light levels, rod cell death results in
night-blindness, leaving daylight vision intact. Much more devastating to patients
are the secondary degenerative changes resulting from rod loss, such as Müller
glial cell hypertrophy, loss of synaptic layers, the death of interneurons and, most
notably, subsequent death of the cone photoreceptors (Figure 1). Although cones
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represent no more than 5% of all photoreceptors in the human eye, their role in
vision is crucial. Cones are required for color vision, and their death leads to
daylight vision loss and ultimately complete blindness (8). Uncoupling the
cellular and molecular mechanisms that link rod cell loss to cone death would
allow cones to survive and patients afflicted with Retinitis Pigmentosa to retain
functional vision.
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Credit: Dr. Andrea Viczian
Figure 1.
Model of retina degeneration. This diagram shows the stages of retina
degeneration. The normal retina has both rod and cone photoreceptors and Müller
glial cells intact. (Stage 1) represents the death of rod photoreceptors, which is
followed by secondary changes, including cone degeneration (stage 2), reactive
gliosis in the form of Müller cell hypertrophy (stage 3) and eventually the death
of inner nuclear cells (late stage 3).
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Mammalian animal models that mimic aspects of Retinitis Pigmentosa
have been critical for investigating the mechanisms of rod cell death, and the
subsequent cone degeneration. Xenopus laevis has been used in the field of
developmental biology for a long time. Awide variety of molecular biology
techniques have been developed for this model organism, and many of the genes
have been identified. Also, it is easy to obtain and maintain large numbers of
Xenopus tadpoles in the laboratory. The Zuber lab recently developed a model of
Retinitis Pigmentosa in the African Clawed Frog, Xenopus laevis (9) to examine
whether Xenopus laevis will exhibit the same secondary cellular changes after rod
ablation. To answer this question, Rene Choi generated a transgenic line of
Xenopus laevis, driving the expression of E. Coli nitroreductase (NTR) under the
control of the rod-specific rhodopsin promoter (XOP). Nitroreductase converts
nitromidazole prodrugs, such as metronidazole (Mtz), into a cytotoxic DNA
crosslinker. Using this drug, Choi and colleagues (9) demonstrated that apoptotic
rods were detected at 24 hours and rod outer segment degeneration was extensive
by five days in Mtz- treated XOPNTR transgenic tadpoles (Figure 2). Also, cone
photoreceptor degeneration and death followed rod ablation (Figure 3).
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Figure 2.
Rod Ablation in XOPNTR Tadpoles
Transgenic (A-C) tadpoles were treated for 5 days with DMSO only (A) or for 5
or 10 days with Mtz (B and C). Retinal sections were stained with rod specific
marker. In comparison to untreated transgenic tadpoles, a clear outer segment was
observed in animals treated for as little as 5 days, and by 10 days of treatment the
only observable rod outer segments was in the most peripheral retina.
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Credit: Rene Choi
Figure 3.
Cone Degenerate after Rod Ablation.
Stage 52 XOPNTR tadpoles were treated with Mtz for 1 to 17 days. Rapid rod
cell loss was observed. The number of cones reduced gradually but significantly,
indicating cone degeneration and pending cone cell death.
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The progressive loss of cones following the initial rapid period of rod
photoreceptor death raises the possibility of rod-cone interactions playing a vital
role in photoreceptor development and survival. Three possible mechanisms have
been proposed to account for consequent cone loss (10). The first postulation
indicates that rod breakdown adversely affects neighboring cones by exposing
outer segments of cones to toxic chemicals that may be released from rod death.
However, rods die by apoptosis, which normally avoids the release of toxic
cellular metabolites that would poison cones, or cause inflammation, and lead to
cone death. A second explanation proposes that oxidative stress is one of the
causes of cone death. This mechanism states that the high metabolic rate of
photoreceptors is an intrinsic risk factor for oxidative damage, especially for
cones, which contain twice as many mitochondrial as rods. Therefore, when rods
are damaged, it results in greater than 90% photoreceptor loss, leaving few
photoreceptors (cones which represent 5% of photoreceptors) to consume the
majority of the oxygen. It is said that this high oxygen concentration may be toxic
for cones, leading to death (11). However in the Xenopus retina, there are equal
numbers of rods and cones, making this mechanism the unlikely cause of cone
death. Thirdly, it is hypothesized that rods produce some kind of signal that is
essential for maintaining cone viability and the disappearance of rods deprives
cones of this signal and triggers their degeneration. This third mechanism has
gained significant traction with the discovery of Rod-derived Cone Viability
Factor-1 (RdCVF1) in the laboratory of Dr. Thiery Léveillard (12).
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RdCVF1 is a protein known to maintain the function and viability of cone
photoreceptor cells in the retina. Nucleoredoxin like1 (Nxnl1) gene,a protein
involved in the defense mechanism against oxidative stress, encodes RdCVF1
(13). In mice, alternative splicing of this gene generates two products. One is
RdCVF1-L, a full-length protein composed of 217 amino acid sequences. This
protein has a putative thioredoxin (enzyme involved in defense against oxidative
stress) activity. The second product is C-terminal post-transcriptionally truncated
protein, with 109 amino acid sequences. This latter form serves as a trophic
factor. Chalmel and colleagues (14) identified RdCVF-2, a protein encoded by the
Nuclearedoxin-Like 2 (NXL2) gene. Alternative splicing also produce a long form,
RdCVF2-L, with putative thioredoxin enzyme activity, and short form, RdCVF2,
with cone survival factors.
Both the RdCVF1 and RdCVF2 proteins have distinct features; there is a
“cap” region, which is the C-terminal region present in RdCVF1/2-Lbut absent in
RdCVF1/2-S, and this portion of the protein gives the long isoforms a putative
thio-oxyreductase activity (14). There is also a conserved active site (CXXC) with
two cysteine residues, but it is unknown if this domain is required for the
proteins’ function. RdCVF2 expression is not restricted to the retina but also in
the brain, testis, placentas and other tissues types (14). However, in the
mammalian retina, RdCVF1 is fully restricted to the eye, where it is expressed
prominently by photoreceptor cells in a rod-dependent manner and also by bipolar
cells in the inner retina (15).
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Our overall hypothesis is that RdCVF1 is expressed in the rods of the
Xenopus laevis retina; rod ablation using the XOPNTR Mtz system results in the
loss of RdCVF1, and, as a result, cone photoreceptors subsequently degenerate
and die. If this hypothesis is true, a Xenopus laevis RdCVF1 ortholog must be
present in the Xenopus laevis genome, and the protein’s functional domains must
be conserved in Xenopus and other species. Also RdCVF1 must be expressed in
the rod photoreceptors of the Xenopus retina.
To determine if a Xenopus laevis RdCVF1 and RdCVF2 ortholog exists,
we used the mouse RdCVF1 and RdCVF2 as a probe, to identify RdCVF1 and
RdCVF2 DNA and protein sequences for homologs from other species. RdCVF1
and RdCVF2 protein sequences are present in the Xenopus genome. Xenopus
RdCVF1is 60.6% identical to mouse RdCVF1, and Xenopus RdCVF2 is 65.2%
identical to mouse RdCVF2. The “cap” regions of both proteins and hydrophobic
residues are conserved in Xenopus and other species. To determine if RdCVF1 is
expressed in the Xenopus retina, I performed in situ hybridization using RdCVF1
RNA probe. RdCVF1 expression was detected in the retina outer nuclear layer,
where rods and cones are located.

Materials and Methods
RdCVF1 and RdCVF2 Sequence Comparison
We used the mouse RdCVF1 and RdCVF2 protein sequences as probes to
identify RdCVF1 and RdCVF2 DNA and protein sequences for homologs
(presumably orthologs) from species using BLAST (Basic Local Alignment
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Search). We then aligned full-length sequences from species using the megAlign
(DNSTAR Inc. Madison WI, USA) and ClustalW algorithm (16). Protein
sequences from thirteen species were aligned for RdCVF1, and protein sequences
from sixteen species were aligned for RdCVF2. RdCVF1 and RdCVF2 protein
sequences were analyzed, and conserved functional domains in Xenopus laevis
and other species were denoted.

Phylogenetic Analysis of RdCVF1 and RdCVF2
RdCVF1 and RdCVF2 mRNA sequences orthologous to mouse RdCVF1
and RdCVF2 were identified using the BLASTn genomic database. The open
reading frame (ORF) of RdCVF1 mRNA sequences from thirteen species were
aligned, and the ORF of sixteen RdCVF2 mRNA sequences were aligned using
MegAlign, (DNSTAR, Inc., Madison WI, USA) ClustalW algorithm (16). Using
this software, a phylogenetic tree was constructed, with 2000 bootstrapping trials
to reconstruct the evolutionary history of the RdCVF protein family.

Generation of Xenopus laevis Embryos
Wild-type females were injected one week and one day prior to egg
collection with pregnant mare's serum gonadotropin (Sigma Aldrich. St. Louis,
MO) and human chorionic Gonadotropin (Intervet, Millsboro, DE) respectively to
induce egg laying, and the eggs were fertilized in vitro using wild-type sperm.
Following fertilization, eggs were sorted through and the ones undergoing proper
divisions were selected. For the first two days, the embryos were housed in Petri
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dishes (Fisher Scientific Inc.) with 0.1XMMR and gentamicin. On the third day,
embryos were moved to Petri dishes containing only 0.1XMMR until the embryos
reached Stage 41/42. Their solutions were changed once a day. Nieuwkoop and
Faber's Normal Table for Xenopus Development was consulted for embryo
staging (17). For the first four days, embryos were kept at 16°C. After stage 42,
when tadpoles began to swim, they were fed in the morning with clear nettle
supernatant and their water was changed in the late afternoon. Two weeks post
fertilization, the tadpoles were transferred to plastic tanks containing water
supplemented with sea salt and phosphates. 25 tadpoles were housed in each
small tank filled approximately halfway to the top with frog water. During this
stage, tadpoles were fed alternate days with supernatant of nettle slurry, and water
was changed three times a week.

Fixing/ Mounting Tadpoles and Cryosectioning
Stage 56 tadpoles were euthanatized in 1% methanesulfonate (Tricaine;
Sigma Aldrich), which was made with 50µl tricaine and 5000µl frog water
(deionized water supplemented with Sodium Phosphate and sea salt). Tadpoles
were placed in 100% Ethanol, fixed in 4% paraformaldehyde for 1 hour, and
immersed in 20% sucrose for 3 hours. Tissues were mounted in OCT and uncut
blocks were stored at -80°C. Tadpole retina was cryostat sectioned (12µm) and
slides were stored at -20°C.
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Synthesis of DIG-labeled XlRdCVF1 RNA probe
Xenopus laevis RdCVF1 circular plasmid was linearized with different
restriction enzymes, SmaI (New England BioLabs Inc.) and NotI (New England
BioLabs Inc.). Restriction digest reaction with SmaI was set up using 64.97µl of
Nuclease-Free water (QIAGEN Inc., USA), 10µl of NEBuffer 4 (New England
BioLabs Inc.), 10µl of BSA (bovine serum albumin, New England BioLabs Inc.),
11.03µl of XIRdCVF1 DNA and 4µl of SmaI enzyme. Restriction digest reaction
with NotI was set up using 64.97µl of Nuclease-Free water, 10µl of NEBuffer 3,
10µl of BSA, 11.03µl of XIRdCVF1 DNA and 4µl of NotI enzyme. Reactions
were incubated for three hours at room temperature. 1µl of each sample was
checked on 1% agarose gel (0.5g of agarose powder, 50mL of 1X TE buffer) for
DNA linearization.
Digested XlRdCVF1 DNA was extracted with 100µl of Phenol:
Chloroform and 100µl of Chloroform: Isoamyl. 10µl of 3M Sodium Acetate in
Diethylpyrocarbonate water was then added. To precipitate the DNA, 250 µl of
100% Ethanol was added to each sample and the tubes were placed on ice for 5
minutes and then centrifuged at maximum speed in a 4°C microfuge (SIGMA
labs Inc.) for 30 minutes. Extracted DNA samples were washed with 250µl of
75% Ethanol and vacuum dried at room temperature for 10 minutes. DNA was
resuspended in 15µl of nuclease-free water and spectra analysis was performed
using NanoDrop spectrophotometer (Fisher Thermo Scientific).
T7 RNA Polymerase-Plus (Roche no. 881 767) was used to synthesis
antisense XlRdCVF1 probe in a reaction with the following components; 12µl
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Nuclease-Free water, 2µl of 10x DIG-labeled mix (Roche no.1277073), 2µl 10X
Transcription buffer, (Ambion no. AM8151G) and 1.9µl of XlRdCVF1 DNA
digested with smaI enzyme. Sp6 RNA Polymerase -Plus (Roche no. 810274) was
used to synthesis sense XlRdCVF1 probe in a reaction with the following
components: 9.2µl of Nuclease-Free water, 2µl of 10x DIG-labeled mix, 2µl 10X
Transcription buffer and 4.08µl of XlRdCVF1 DNA digested with NotI enzyme.
Reaction was incubated for 3 hours at 37°C, then 1µl DNaseI (Thermo
Scientific no. 89835) was added and incubated for 10 minutes at 37°C. 1µl 0.5M
EDTA, pH 8.0 was added to stop reaction and 1µl of sample was removed to
check on 1% agarose gel. 1.5µl LiCl, 66µl 100% Ethanol was added and tubes
incubated at -20°C overnight for DNA precipitation. Precipitated RNA was
centrifuged at 15,600 rcf in microfuge for 15 minutes at 4°C. Supernatant was
poured off and 100 µl of RNF 75% Ethanol was added. Excess Ethanol was
removed and RNA was resuspended in 20 µl Rnase Free water (QIAGEN). RNA
spectrophotometer analysis was performed using NanoDrop spectrophotometer
and XlRdCVF1 RNA sense and antisense probes were resuspended in
hybridization buffer for a final concentration 20µg/mL.

In Situ Hybridization
In situ hybridization is a technique that relies on the hybridization of a
specific labeled nucleic acid probe with an individual cell or tissue.
Slide Preparation
Slides were thawed out at room temperature for 30 minutes, washed in 1X
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PBS (5 mL 10X PBS and 54 mL water), 100% Methanol, Ptw (50 mL of 10X
PBS, 5mL of 10% Tween-20 and 445 mL water).
Pretreatment & Hybridization
PAP pen liquid blocker (Fisher Scientific no. NC972045) was used to
label the edges of slides and Xenopus retina tissue sections were treated with
Proteinase K for 30 seconds. Slides were washed in Glycine (100 mg Glycine and
50 mL of Ptw), and Ptw solutions and sections were fixed in 0.2% Glutaraldehyde
solution (8 µl Glutaraldehyde and 1 mL of 4% PFA). They were then washed in
Ptw, sodium borohydride and in hybridization buffer. Sections were prehybridized in hybridization buffer (25 mL Deionized formamide, 7.5 mL 5M
NaCl, 5mL 10X PE, 0.5 mL 10mg/ml tRNA, 0.5mL 5% heparin, 2.5 20% SDS
and 9 mL DEPC'd water) at 62°C for 1 hour. 100 µL of probe was added to slide
coverslips and slides were inverted onto the coverslip with probe. XlRdCVF1
probe synthesized with T7 Polymerase-Plus was used as the antisense
experimental group, and XlRdCVF sense probe synthesized with Sp6 PolymeraePlus was used as the negative control. Slides were sealed with DPX (EMS no.
13514) and incubated overnight at 60°C.
Washing
Retina tissue sections were washed in hybridization buffer for 15 minutes
at 60°C, in washing buffer -1 (3mL 5M NaCl, 5mL 10X PE, 2.5mL 20% SDS,
39.5mL water) at 60°C, in washing buffer-1.5 (500µl 5M NaCl, 5mL 10X PE, 250
µL 20% SDS, 44.5mL water) at 50°C, and rinsed briefly in NTE buffer (5mL 5M
NaCl, 500 µL 1M Tris-Cl pH 8.0, 100 µl 0.5 EDTA and 44.4 mL water). Sections
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were washed with 100 µg/ml RnaseA in NTE (5 µL of 20mg/mL RnaseA, 995 µl
NTE) for 45 minutes at 37°C and rinsed briefly in NTE buffer. Sections were
washed for 15 minutes with washing buffer -2 (15 mL 100% Formamide, 1.8mL
5M NaCl, 3 mL 10X PE, 1.5mL20% SDS and 8.7mL water) at 50°C water bath,
in washing buffer-3 (15mL 100% Formamide, 900 µl 5M NaCl, 3mL10X PE, 300
µl 10%-Tween-20 and 10.8mL water) for 15 minute at 50°C water bath, and in
washing buffer-4 (5mL 5M NaCl, 5mL 10X PE, 500 µl of 10%-Tween-20 and
39.5mL water) at room temperature for 2 minutes then at 70°C water bath for 10
minutes. Sections were treated with IXMABT, 2mM levamisole and 2% BMBR
(100 µL 10X MAB, 10 µl 10%-Tween-20, 2µL 1M levamisole, 200 µL 10%
BMBR, and 688 µL water) for 30 minutes at room temperature and then treated
with (1/2000) anti-DIG AP in 1XMABT, 2mM Levamisole and 2% BMBR (100
µL10X MAB, 10 µl 10%-Tween-20, 2µL 1M levamisole, 200 µL 10% BMBR,
0.5 µL anti-DIG AP and 687.5µL water) overnight at room temperature.
Probe Detection
Sections were washed with 2mM levamisole 1X MABT (300 µL 10X
MAB, 30 µL 10%-Tween-20, 6 µL 1M levamisole and 2.664mL water) for 10
minutes, in AP Development Buffer (25µL 1M Levamisole, 500 µL 1M Tris-Cl
pH 9.5, 100 µL 5M NaCl, 500 µL10%-Tween-20 and 3.825mLwater) for 2
minutes. BM purple AP Substrate solution with 2mm Levamisole (I mL BM
purple solution, 2 µL 1M Levamisole) was added to sections and slides were
incubated at room temperature for 2 days. Sections were washed with
PTw+EDTA and DAPI (300 µL 10X PBS, 30µL 10%-Tween-20, 6 µL of 0.5
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EDTA, 1 µL and 6 µL water), and in Ptw and EDTA solution. FluroSave (VWR)
with 4-Diazabicyclo [2.2.2] octane (DABCO, Sigma Aldrich) solution was added
to slide coverslip, slides were inverted onto the coverslip and sealed slides were
kept at -20°C.
Microscopy
Stained sections were visualized using a Leica DM600 B upright
fluorescence light microscope with motorized Z-focusing (Leica Microsystems,
Bannockburn, IL), fitted with a Retiga-SRV camera (Q-Imaging, Surrey, BC,
Canada) for image capture. Images were processed using volocity software 5.0.3
(Improvison Inc.a PerkinaeElmer Company, Waltham, MA).
Generation of XOPNTR Transgene and Transgenic Animals (9)
Rene Choi from the Zuber lab generated transgenic XOP-NTR animals.
The transgene construct pXOP(-508/+41)-NTR was generated by replacing eGFP
of pXOP(-508/+41)GFP with the E. coli nitroreductase gene. XOPNTR F0
transgenic Xenopus laevis were generated using restriction enzyme-mediated
integration, and four XOPNTR founders, two males and two females, were grown
to adulthood. 21 progeny from the founder females, XOPNTR1 and XOPNTR2,
were generated, and only XOPNTR2 tadpoles responded to metronidazole
treatment.
Generation of F1
The transgenic female was injected 1 week and one day prior to egg
collection with pregnant mare’s serum gonadotropin (Sigma Aldrich, St. Louis,
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MO) and human chorionic gonadotropin (Intervet, Millsboro, DE), respectively,
to induce egg laying, and the eggs were fertilized in vitro using wild-type sperm.
Genotyping
Stage 50-56 XOPNTR tadpoles were tail snipped and DNA was isolated
using DNeasy Blood & Tissue Kit (Qiagen Incorporated, Valencia, CA).
NanoDrop spectrophotometer was used to calculate DNA concentration.
Polymerase Chain Reaction (PCR) was set up using NTR primers, 10Mm
DNTP'S, dimethyl sulfoxide, Nuclease Free H20, 10X Econotaq buffer and
Econotaq enzyme. Primers specific for the transgene
(5’ XOPNTR: 5’-CGCTAAATCCTTTGTTGCTGACGC-3’
3’ XOPNTR: 5’-GTTGAACACGTAATTACCGGCAGC-3’) were used
to identify transgenic tadpoles from their non-transgenic siblings. Gel
electrophoresis was performed using 1% agarose gel, and transgenic animals were
separated from their non-transgenic siblings.
Metronidazole Treatment
Metronidazole (Sigma Aldrich, no. M-1547) was dissolved in 0.1X MMR
Containing 0.4% DMSO (Sigma Aldrich no. D8418) to a final concentration of
10mM immediately before use. 4 PCR positive XOPNTR animals between stages
50-54 were treated with Metronidazole and 4 PCR positive XOPNTR animals,
serving as experimental control animals, were cultured in DMSO solution without
metronidazole for 14 days. Preliminary experiments demonstrated that higher
concentrations of metronidazole were toxic. Tadpoles were raised at 22˚C in
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complete darkness for the indicated time because metronidazole is light sensitive.
Solutions were changed and animals were fed alternate days.
Immunohistochemisty
Retina sections of Stage 56 wild type, transgenic treated and transgenic
untreated tadpoles were washed in methanol, blocking solution containing 1X
PBS, 0.1X Triton, 5% HIGS and water. Slides were incubated overnight in
primary antibody, anti-Transducin polyclonal (1:100; no. Sc-389, Santa Cruz
Biotechnology, Santa Cruz, CA) prepared in a solution containing 1X PBS, 0.1X
Triton, 5% HIGS and water. The following day, slides were washed in 1X PBS
solution and incubated in donkey anti-rabbit IgG Alexa 488 (1:500; no. A-21206)
secondary antibody tagged with fluorescent molecules. The slides were mounted
in a solution of FluorSave reagent (VWR), 2% 1,4Diazabicyclo[2.2.2]octane (DABCO, Sigma Aldrich) and 10 mg/ml 4,6Diamidino-2-phenyindole, dilactate (DAPI, Sigma Aldrich).

Results
As in the mammalian retina, cone cell degeneration and eventual death
follows rod ablation in Xenopus laevis. Our hypothesis is that RdCVF1 is
expressed in the rods of the Xenopus retina, and cone cell degeneration and death
result from the loss of RdCVF1 following rod ablation. If this postulation is true,
RdCVF1 protein ortholog must be present in the Xenopus genome, RdCVF1
functional domains must be conserved among species including Xenopus, and
RdCVF1 must be expressed in the rod photoreceptors of the Xenopus retina.

20

Similar
30

M!L!F!L!N!N!D!DE!!EL!!NL!!FC!F!!P!LF!L!TDEFYV!RQ!L!!Y!S!DF!L!P!L!!
20

40

50

60

70

170

80

180

90

190

100
100
100
100
100
100
100
100
100
100
100
100
100
100

200
200
200
199
199
199
194
199
199
199
199
196
199
199

215
215
217
212
215
204
218
214
218
212
207
211
227

Sequence Conservation of RdCVF1 Proteins

10

RdCVF2

160

MADLFLDKILVKNNRDQDELDTEREIWERLENRVILLFFAKSRSSQCQEFAPLLKDFFVRLTDEFYVDRSSQLALVYVSLDQSEEEQERFLKDMPKRWLF
MADLFLGKVLVKNNRDQDELDTEREIWERLQNRVILLFFARSRDSQCQEFAPLLKDFFVRLTDEFYVNRASQLALVYVSLDQSEEEQEKFLKDMPKRCLF
MASLFSGRILIRNNSDQDEVETEAELSRRLENRLVLLFFGAGACPQCQAFAPVLKDFFVRLTDEFYVLRAAQLALVYVSQDPTEEQQDLFLRDMPEKWLF
MASLFSGRILIRNNSDQDELDTEAEVSRRLENRLVLLFFGAGACPQCQAFVPILKDFFVRLTDEFYVLRAAQLALVYVSQDSTEEQQDLFLKDMPKKWLF
MVDLFLGKVLVKNNKDRDELDTEREIILRLQNRILMLFFGSGDSEKCQDFAPTLKDFYKKLTDEFYVERSAQLVLLYISLDSSEEQQEKFLKELPKRCLF
MAALFSGRVLIRNNSDQDELDTEEELSRRLENRLVLLFFGAGDCPRCQAFAPVLKDFFVRLTDEFYVLRAAQLALVYVSQDPTEEQQDQFLRDMPKKWLF
MASLFSGRVLIRNNSDQDELDTEAELSRRLENRLVLLFFGAGSCPQCQAFAPILRDFFVRLTDEFYVLRAAQLALVYVSQDPTEEQQDLFLRDMPKKWLF
MASLFSGRVLIRNNSDQDELDTEAELSHRLENRLVLLFFGAGSCPKCQAFAPILRDFFVRLTDEFYVLRAAQLALVYVSQDPTEEQQDLFLRDMPKKWLF
MASLFSGRVLIRNNSDQDELDTEAELSRRLENRLVLLFFGAGSCPECQAFAPILRDFFVRLTDEFYVLRAAQVALVYVSQDPTEEQQDLFLRDMPEKWLF
MASLFSGRILICNNNDQDELDTEAEVSRRLENRLVLLFFGAGACPQCQAFVPILKDFFVRLTDEFYVLRAAQLALVYVSQDSTEEQQDLFLKDMPKKWLF
MASLFTGKVLIVNNRDRDEMETERELCLALENRVMLLYFGAAECPRCRSFVPRLKDFFVRLTDEFYVERASQLCLVYVSRDATAQQEEAFLKSMPKRWLS
MAALFINKTLIVNNKDNDKLELERELICALENKVMLLYFGSSECPKCKEFAPILKEFYVRLTDEFYVERASQLVLVYVSLDETEEKQDEFLKKMPKRWLF
MVDLFIDRVLLKNNKDQDELDTEREIIMRLQNRILMLFFASATCETCRQFAPTLSDFYKQLTDEFYVDRAAQLVLLYISLDQSEEEQESFLKELPKRCLF

RdCVF1

27.6%
28.8%
---32.2%
32.7%
30.8%
32.7%
32.7%
32.1%
30.8%
34.0%
30.1%
28.1%

150

53.5%
56.2%
--79.5%
82.4%
49.8%
79.7%
80.2%
70.9%
76.4%
56.6%
52.2%
45.6%

140

Xenopus laevis
Xenopus tropicalis_P
Mouse
Human
Zebrafish
Elephant_P
Dog _P
Pig_P
Cattle _P
Rhesus Monkey_P
Wild Turkey_P
Arboreal Lizard_P
Cichlid Fish_P

130

!D!L!F!V!P!VL!P!E!G!CN!W!E!R!F!E!RS!!RR!KY!!
120

Similar

VPFKDEEFRRNLEAQFSVSRVPVLVVLKPSGHVISFNAVDEVVRLGPPCFKNWQEVSEIIDRSFLLPEFTDDRAGRSMTDPIRRIKYKDETTNEKKKRKH
VPFKDEEFRRNLEAQFAVSHVPVLVVLKPSGHVISFNAVDEVVRLGPPCFKNWQEVSEIIDRSFLLPEFTDDRAGRSMTDPIRRIKYKVESPDDKKKRKH
LPFHD-ELRRDLGRQFSVRQLPAVVVLKPGGDVLTSDATEEIQRLGPACFANWQEAAELLDRSFLQPEDLDEPARRSITEPLRRRKYRVDRDVGRERGRN
LPFED-DLRRDLGRQFSVERLPAVVVLKPDGDVLTRDGADEIQRLGTACFANWQEAAEVLDRNFQLPEDLEDQEPRSLTECLRRHKYRVEKAARGGRDPG
LPYED-PYRQELGVMFEVRDLPRVVVLRPDCSVLSPNAVSEICTLGTDCFRNWQEGAELIDRNFMMNEEFDEGKMRSMTDPIRRIKYKVEDEKKKKKKRD
LPFQD-DLRMDLGRRFSVERLPAVVVLKPGGDVLTRDAADEIRRLGPACFANWQEAAELLDRSFLQPEDLDDPAPRSLTEPLRRRKYRVDAAPRG----LPFED-DLRRDLGRRFSVERLPAVVVLKPGGDVLSRDATDEIRRLGPACFANWQEAAEVLDRNFLQPEDLDDPAPRSLTEPLRRCKYRVDREARGKRGPG
LPFED-DLRRDLGRRFSVERLPAVVVLKPGGDVLTLDAVDEIQRLGPACFANWQEAAEVLDRSFLQPEDLDDPAPRSLTEPLRRCKYRVDRAARGSHGRE
LPFED-DLRRDLGRQFSVERLPAVVVLKPSGDVLTLDAADEIRRLGPACFANWQEAAEVLDRSFLQPEDLDDPAPRSLTEPLRRCKYRVDPAARRARGRG
LPFED-ELRRDLGRQFSVERLPAVVVLKPDGDVLTRDGADEIQRLGTSCFANWQEAAEVLDRNFQLPEDLEDQEPRSLTECLRRRKYRVEKAARGGRDPG
LPFGD-EFKRELEQRFEVSEVPRVVVLKPNGDVIVGNAVDEITSMGPACFQNWREAAELVDRNFRLAEDFDDCARRSITDPLRRLKYKLCKGE---ESRS
LSFDD-DFKRELELRFSVKTPPVVVVLKPNGDIIAANAVEEIKQAGTACFKNWQEAADLVERNFRLQEDFGPLTLRSITDPLRRLKYKVAKDKRRKKDKD
LAYED-PYRRELEAMFNVEEVPTVLVLRPDCSILIPNAVDEILRLGPDCYRNWQEAAELIDRNFVNKEDFEEKSMRSFSDPVRRLKYKVEDEKKKKKKKK

110
Xenopus laevis
Xenopus tropicalis_P
Mouse
Human
Zebrafish
Elephant_P
Dog _P
Pig_P
Cattle _P
Rhesus Monkey_P
Wild Turkey_P
Arboreal Lizard_P
Cichlid Fish_P
!

-------CDDEDEGGGG------GTEFF
-------CDDEEEGGGG------GTELF
G-----RDSGDPQGDAG-----TRAELW
-------GGGGEEGGAG--------GLF
--------DDDDDDDGG-----GGGGPWG
----------GPEGGAG--------GLF
GGS-QPEGGRGAEGGAG--------DLF
R-----EGCPRREDGAE--------ELF
R-----AGGSGQEGEAEG----EAAGLF
-------GGGGEEGGAG--------GLF
--------EEQKEDGDG--------SS
--------EGEDEDKDN--------AFS
RKGWGGGGDEGVEADGGAGDKEGGGSPW

210

Similar

Xenopus laevis
Xenopus tropicalis_P
Mouse
Human
Zebrafish
Elephant_P
Dog _P
Pig_P
Cattle _P
Rhesus Monkey_P
Wild Turkey_P
Arboreal Lizard_P
Cichlid Fish_P

Figure 4.

21
Figure 4 shows the multiple alignments of existing and
predicted RdCVF1 full -length proteins. (GenBank
Accession numbers for these sequences can be found in
appendix A). Organism names of each protein sequence
are listed on the left and predicted sequences are denoted
(_P). Percent identity of species RdCVF1 to the mouse
RdCVF1 and RdCVF2 is listed at the bottom panel.
Residues identical in all species are highlighted in yellow,
hydrophobic residues (A,C,E, F,G,I,L,M,S,T,V,W,Y) are
marked with black triangles. Catalytic (CXXC) sites are
shown (red arrow) and the red box around the residues,
blue arrow represents the beginning of the “cap” region.
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Figure 5 shows the multiple alignments of existing and
predicted RdCVF2 full-length proteins. (GenBank Accession
numbers for these sequences can be found in the appendix B).
Organism names of each protein sequence are listed on the left
and predicted sequences are denoted (_P). Percent identity of
species RdCVF2 to the mouse RdCVF1 and RdCVF2 is listed
at the bottom (right). Residues identical in all species are
highlighted in yellow, and hydrophobic residues (A,C,E,
F,G,I,L,M,S,T,V,W,Y) are marked with black triangles.
Catalytic (CXXC) sites are shown (the red arrow) and the red
box around the residues, and the blue arrow represents the
beginning of the “cap” region.
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Analysis of RdCVF1 and RdCVF2 Protein Sequence
Chamel and colleagues (14) identified RdCVF2, another bifunctional
protein belonging to the Rod-derived Cone Viability Factor family. This isoform
shares many similarities with RdCVF1 in terms of the gene structure. I asked
whether RdCVF1 and RdCVF2, and in particular the domains of the proteins
required for their function, are conserved among species, especially in Xenopus. I
used the mouse RdCVF1 and RdCVF2 protein sequences as probes to identify
RdCVF1 and RdCVF2 DNA and protein sequences for homologs (presumably
orthologs) from species using BLAST. I then used the program megAlign
(DNASTAR, Madison WI .USA) and ClustalW algorithm (16) to align the
sequence and determine if functional domains are conserved in Xenopus. Only
full-length sequences were used. Protein sequences from thirteen species were
aligned for RdCVF1 and protein sequences from sixteen species were aligned for
RdCVF2.
RdCVF1 aligned protein sequence (Figure 4) showed conserved active
sites (CXXC) with two distinct cysteine residues in all species except Xenopus
laevis, Xenopus Tropicalis and Zebrafish. This site confers a thiol-reductase
activity on RdCVF1 (14). In Xenopus, the first cysteine is replaced by a serine. A
conserved “cap” region is present in all the species. The “cap” is the C-terminal
region present in RdCVF1/2-L but absent in RdCVF1/2-S. This portion of the
protein gives RdCVF1/2-L a putative thio-oxyreductase activity (14).
Hydrophobic residues (A,C,F,G,I,L,M,S,T,V,W,Y) are conserved in all the
species. This hydrophobic patch is more prevalent in the sequences before the
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“cap” region and it is where RdCVF1and RdCVF2 interact with other proteins or
cell membrane structures (14). RdCVF2 aligned protein sequences (Figure 5)
have conserved active sites (CXXC) with two distinct cysteine residues in all
species. There is also a “cap” region in all species and hydrophobic resides are
also conserved.
I conclude that RdCVF1 and RdCVF2 are present in the Xenopus genome.
In Xenopus RdCVF1, the first cysteine residue at the catalytic site is not
conserved. Instead of CXXC, serine has replaced the first cysteine making the
active site SXXC. The “cap” region and hydrophobic residues are found in
Xenopus.
Conservation of RdCVF1 Gene Structure
Cone viability is dependent on the production of RdCVF1-S form. In
mouse, this isoform is generated by the presence of a stop codon at the end of the
first exon of RdCVF1 and RdCVF2 (14). To evaluate if this stop codon is present,
we aligned RdCVF1 gDNA, mRNA and protein of Xenopus and mouse. Xenopus
laevis genome was provided by Richard Harlands lab (University of California,
Berkeley), and Reyna Martinez from the Zuber lab blasted the genome to obtain
Xenopus RdCVF1 genomic DNA. The stop codon at the end of the first exon is
strictly conserved in mouse and Xenopus (figure 6). This observation does not
prove that RdCVF1-S exists in Xenopus but implies a possible existence.
GenBank Expressed Sequence Tag databases were searched for RdCVF1/2 short
isoforms, and I was unable to find any EST’s. From this result, I conclude that
RdCVF1-S isoform could be present in Xenopus laevis.
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Mouse_DNA

GAA CTG AGG AGG TGA GGC CCC

X. laevis _DNA

GAA TTC AGG AGG TGA GAT AGG

Mouse_mRNA

GGU GCG GCU AGG UGA GAC CUC

X. laevis_ mRNA

ACA AAA UUU UGG UGA AAA AUA

Mouse_ A.A

E

L

R

R

*

D

X. laevis _A.A

E

F

R

R

*

D R

L

Figure 6.
Conservation of Xenopus and Mouse RdCVF1 Stop Codon.
Mouse and Xenopus DNA, mRNA and amino acid sequences are aligned.
Organism name is listed (left). The genomic region surrounding the stop codon at
the end of the first coding exons of mouse and Xenopus RdCVF1 are aligned.
Conserved stop codons are colored in red. (GenBank Accession numbers are
listed on appendix D).
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Figure 7.
Phylogenetic Tree of RdCVF Family.
Figure 7 shows the evolutionary relationship of RdCVF1 and RdCVF2. Organisms
are grouped in their respective classes. RdCVF1 species are grouped together at
the bottom and RdCVF2 species are grouped together at the top. The arrow points
to the Xenopus laevis RdCVF1 I use in the lab. (GenBank Accession numbers are
listed on appendices C and D).
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Phylogenetic Analysis of RdCVF1 and RdCVF2
Chamel and colleagues identified a protein paralogous to RdCVF1 in
mouse, RdCVF2. Both have similar protein sequences and gene structures are
highly similar. It is shown that the degree of homology between RdCVF1 and
RdCVF2 is 58.0% for the long isoforms and 53.5% for the short isoforms (14). It
is important to reconstruct evolutionary history of the RdCVF family to determine
if the RdCVF sequence used in our lab is RdCVF1. mRNA sequences orthologous
to mouse RdCVF1 and RdCVF2 were identified using the BLASTn genomic
database. The open reading frame (ORF) of RdCVF1 mRNA sequences from
thirteen species were aligned and sixteen ORF of RdCVF2 mRNA were aligned
using MegAlign (DNASTAR, Madison, WI USA), CrustalW algorithm (16) and
the software was used to construct a phylogenetic tree.
RdCVF1 sequences grouped together on the phylogenetic tree away from
RdCVF2 group (Figure 7). For all the species aligned, RdCVF1 sequence
similarity as compared to the mouse RdCVF1 (Figure 4) ranged from 45.6%
(cichlid fish) to 82.4% (elephant). The sequence similarity of all species aligned
RdCVF1 sequence compared to the mouse RdCVF2 ranged from 27.6% (Xenopus
laevis) to 34.0% (wild-turkey). The Xenopus laevis RdCVF that we have in the
lab is 53.5% similar to mouse RdCVF1 and only 27.6% similar to mouse
RdCVF2. From these results, I conclude that the Xenopus laevis RdCVF we use
in the lab is most likely the Xenopus laevis ortholog.
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Expression Pattern of Xenopus laevis RdCVF1
In the mouse Retinitis Pigmentosa model, RdCVF1 protein expression is
rod dependent and mainly expressed in the Outer Nuclear Layer (ONL) of the
retina. Also, Reichman and colleagues (18) demonstrated that RdCVF1 is
expressed slightly in the Inner Nuclear Layer (INL), specifically in bipolar cells.
If RdCVF1 is present in our Xenopus model, then it should be expressed similarly.
I prepared RdCVF1 probe and performed in situ hybridization to examine the
expression pattern.
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Figure 8a.
Circular plasmid of Xenopus laevis RdCVF1 (XlRdCVF1). This
figure represents the plasmid that was linearized to synthesize
XlRdCVF1 probe. NotI and SmaI restriction sites are indicated.
The open reading frame of the DNA is marked (blue arrow). The
Sp6 forward promoter and T7 reverse promoter are also shown.
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Figure 8b.
Gel Electrophoresis Analysis of Linearized XlRdCVF.
Lane 1, 10 kb ladder; lane 2, XlRdCVF digested with NotI enzyme; lane 3,
XlRdCVF1 digested with SmaI enzyme; lane 4, undigested XlRdCVF1.
Undigested plasmid size is about 5 kb.
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Sample ID

ng/µl

A260

A280

260/280

M100 Not 1

352.88

8.82

4.38

2.02

617.25

15.43

7.6

2.03

Sp6
M100 Sma1
T7
Figure 8c.
Spectra Analysis of Xenopus RdCVF1 Probe. Probe concentration was (ng/µl)
calculated using NanoDrop spectrophotometer. RNA has absorption at 260 nm.
The ratio of absorbance at 260 nm, and 280 nm is used to assess the purity of
RNA.
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Figure 8d.
Gel Electrophoresis Analysis of XLRdCVF1 Probe. Lane 1, 10 kb ladder; lane
2, anti-sense XLRdCVF1 probe synthesized with T7 RNA Polymerase-Plus; Lane
3, sense XlRdCVF1 probe synthesized with Sp6 RNA Polymerase-Plus.
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Probe Preparation
Xenopus laevis RdCVF1 circular plasmid (Figure 8a) was linearized by
restriction enzyme digest using Sma1 and Not1 restriction enzymes (Figure 8b). I
extracted the linearized DNA by Phenol: Chloroform extraction. XlRdCVF-NotI
DNA, transcription buffer, DIG-labeling mix and Sp6 RNA Polymerase -Plus
were used to synthesize RdCVF1 sense probe. XlRdCVF1-SmaI DNA and T7
RNA Polymerase- Plus were used to synthesize RdCVF1 anti-sense probe. The
probe concentration and purity was analyzed (Figure 8c), using a Nanodrop
spectrophotometer (Thermo Fisher Scientific Inc. USA ), and I also checked the
purity of the probe on agarose gel (Figure 9d). 2.02 and 2.03 260/280 indicated
that the probe didn’t have any protein contamination. The probes were
resuspended in hybridization buffer.

In Situ Hybridization
In situ hybridization uses a labeled a complementary DNA or RNA strand
such as a probe to localize a specific DNA or RNA sequence in a tissue. I used a
DIG-labeled anti-sense XLRdCVF probe to localize the expression of RdCVF1 in
the Xenopus retina. A DIG-labeled sense XLRdCVF probe was used as a control.
In retina tissue stained with the anti-sense probe, RdCVF1 expression was
localized in the outer nuclear layer of the Xenopus retina where rod and cone
photoreceptors are located. I also observed a slight expression in the Inner nuclear
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layer (Figure 10, panels A and A’’). Retina stained with sense probe (Figure 10,
panels C and C’’), RdCVF expression was not detected in the retina. The nucleus
of all retina sections was stained with DAPI. Results from the In situ
hybridization experiment conclude that RdCVF1 is expressed in the outer nuclear
layer and also possibly in the inner nuclear layer of the Xenopus retina.
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!
Figure 9.
In situ Localization of Xenopus RdCVF1: Antisense Probe.
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Figure 9 shows In Situ hybridization results using XLRdCVF
anti- sense probe (Panels A-A”). RdCVF1 expression is the
purple staining (arrow on panel A”) on panels (A) and (A”).
Panel (A) was taken with 10X magnification and A’’ had
20X magnification. The retina Outer Nuclear Layer (ONL),
Inner Nuclear Layer (INL), Ganglion Cell Layer (GCL), and
lens (L) are indicated. Panel (B) shows the section of the
retina stained with DAPI (blue) in 10X magnification and
panel (B”) is 20X magnification of retina section stained
with DAPI.
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A
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GCL

B

B”
Figure 10.
In Situ Localization of Xenopus RdCVF1: Sense Probe
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Figure 10 shows In Situ hybridization results using a XLRdCVF
sense probe (Panels A-A”) RdCVF1 expression is not detected,
and purple staining was not observed (arrow on panel A”) on
panels (A) and (A”). Panel (A) was taken with 10X
magnification and A’’ had 20X magnification. The retina outer
nuclear layer (ONL), Inner Nuclear Layer (INL), Ganglion Cell
Layer (GCL) and lens (L) are indicated. Panel (B) shows the
section of the retina stained with DAPI (blue) in 10X
magnification, and panel (B”) is 20X magnification of retina
section stained with DAPI.
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XOPNTR-Rod Ablation System
In situ hybridization detected RdCVF1 expression in the Xenopus laevis
retina. This result is consistent with the hypothesis that RdCVF1 is expressed in
the Xenopus retina in a rod dependent manner. Rene Choi from the Zuber lab
generated transgenic Xenopus laevis expressing the Escherichia coli enzyme
nitroreductase (NTR) in retinal outer nuclear layer, under the control of a rodspecific rhodopsin (XOP) promoter (Figure 11a). Treating transgenic animals
with metronidazole resulted in complete ablation of rod photoreceptors on the
12th day of treatment. I decided to test this rod-ablation system for two purposes:
to test whether RdCVF1 expression will be lost in XOPNTR metronidazole
treated animals, and also to determine if RdCVF1 is only expressed in rods of the
retina outer nuclear layer. I performed PCR to identify transgenic tadpoles using
primers specific for the transgene (Figure 11b for PCR results).
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Figure 11a.
Circular plasmid of XOP-NTR System. This figure shows the Xenopus laevis
rhodopsin promoter driving the expression of E. coli nitroreductase enzyme.
Forward and reverse primers are denoted (red triangles,) and the open reading
frame of the DNA is shown (black arrow).
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PCR Identification of Transgenic Xenopus laevis Tadpoles.
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Immunohistochemistry
After identifying transgenic tadpoles, wild type and transgenic tadpoles
were treated with metronidazole for 10 days. At the same time, a group of
transgenic tadpoles was left untreated (placed in DMSO solution) for ten days. I
sectioned the retina of these tadpoles and performed immunohistochemistry using
anti-Transducin polyclonal (1:100; product # Sc-389, Santa Cruz Biotechnology,
Santa Cruz, CA). All the sections were also stained with DAPI to label the nuclei.
Wild type, metronidazole treated animals had their retina outer segments intact
after 10 days of treatment (Figure 12). Transgenic animals that did not receive
treatment also didn’t exhibit any loss of retina outer segments (Figure 13). On the
hand, transgenic animals that were treated with metronidazole showed outer retina
outer segment degeneration (Figure 14). These results confirmed that the lab’s
XOPNTR- rod ablation system is working. In future experiments, we will
examine the effect of rod ablation on Xenopus laevis RdCVF1 expression and also
determine if RdCVF1 is only expressed by rods in the retinal outer nuclear layer.
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Figure 12.
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Transducin Staining of Wild Type Xenopus laevis Treated with
Metronidazole.
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Panel (A) is a 10X magnification of retina section of treated wild
type animals. The lens is labeled (L). Panel (B) is 20X
magnification of the same retina section and the arrow point to
the retina outer segment. Panels (B) and (B”) are the same retina
sections stained with transducin and panels (C) and (C”) are the
same retina sections stained with DAPI.

Figure 13.
Transducin Staining of Untreated XOPNTR Xenopus laevis

A

A”

46

L
B

B”
Panel (A) is a 10X magnification of retina section of treated wild type
animals. The lens is labeled (L). Panel (B) is 20X magnification of the same
retina section and the arrow point to the retina outer segment. Panels (B)
and (B”) are the same retina sections stained with transducin and panels (C)
and (C”) are the same retina sections stained with DAPI.
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Transducin Staining of XOPNTR Xenopus laevis Treated with
Metronidazole.
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Figure 14.
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Panel (A) is a 10X magnification of retina section of treated
wild type animals. The lens is labeled (L). Panel (B) is 20X
magnification of a different retina section and the arrow point
to the retina outer segment. Panels (B) and (B”) are the
different retina sections stained with transducin and panels (C)
and (C”) are the different retina sections stained with DAPI.

Discussion
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As in the mammalian retina, cone degeneration and eventual cell death
follows rod ablation in Xenopus laevis. I hypothesized that the protein RdCVF1 is
expressed in the rods of Xenopus retina and cone degeneration and cell death
result from the loss of RdCVF1 expression. I report that RdCVF1 ortholog exist
in the Xenopus genome, and most of RdCVF1 functional domains are conserved
in Xenopus and other species. Also, RdCVF1 is expressed in the outer nuclear
layer of the Xenopus retina and potentially in the inner nuclear layer.
Conservation of Xenopus laevis RdCVF1
Xenopus laevis RdCVF1 amino acid sequence, just like the mouse
RdCVF1 sequence, has a conserved “cap region” and hydrophobic residues that
are more prevalent in regions before the “cap.” However, unlike the mouse
sequence, Xenopus RdCVF1 doesn’t have the catalytic (CXXC) region with two
distinct residues. Instead Xenopus RdCVF1 has (SXX), a cysteine to serine
substitution. Although it is proposed that this sequence region confers thiolreductase activity on RdCVF1 (14), it is unclear if the CXXC region is required
for RdCVF1 protein function. In order to determine the importance of this
catalytic site, we will need to design an experiment to rescue cone degeneration
after rod ablation by expressing RdCVF1 in a rod-less Xenopus retina. If we are
not able to stop cone death while expressing RdCVF1 in the absence of rods, then
it may be possible that the cysteine to serine base substitution might be critical to
the protein function. Results from the experiment will determine if CXXC region
is vital for RdCVF1 protein function. If it is this, we can change the serine to a
cysteine at the catalytic site.
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Chalmel and colleagues (14) showed that in mouse cone viability is
dependent on the production of the RdCVF1-S, and this isoform is generated by
the presence of a stop codon at the end of the first exon of RdCVF1. In Xenopus
RdCVF1 genomic DNA, there is also a stop codon at the end of the first exon.
However, this does not prove that RdCVF1-S exists in Xenopus. To confirm that
RdCVF-S is present in the Xenopus retina, we can design an experiment to test
specifically for this isoform. We can generate probes that only detect RdCVF1
and perform in situ experiments to determine whether there is an RdCVF1
expression. We can generate this probe by isolating RNA and performing PCR to
amplify the 3’UTR region of RdCVF1. We can also make primers that will only
amplify the region of RdCVF1 gene known to be present in the short isoform
only. It is important to determine if RdCVF1-S is present in Xenopus retina
because this isoform is the cone trophic factor.

Expression Pattern of Xenopus laevis RdCVF1
The In situ hybridization experiment localized RdCVF1 expression in the
outer nuclear layer of the Xenopus retina, where rods and cones are located. I also
observed a light expression in the inner nuclear layer. Although I know that
RdCVF1 is expressed in the Xenopus retina, my result does not indicate the
specific retina cell type that expresses the protein. To determine whether rods or
other retinal cell types are expressing RdCVF1, we can perform in situ
hybridization using a XlRdCVF1 RNA probe and use cell specific markers to
label rods, cones and bipolar cells. Also, we can test the loss of RdCVF1
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expression in the retina of transgenic XOPNTR metronidazole treated animals by
performing in situ hybridization on retina sections of untreated XOPNTR and
treated XOPNTR animals to detect the levels of RdCVF1 expression. Cones could
be labeled with calbindin to detect the loss of cones in the rod-ablated retina. We
expect undetected RdCVF1 expression in the outer nuclear layer of XOPNTR
treated, since rods are ablated, and also we expect to see fewer cone cells in that
retina.
Our hypothesis that RdCVF1 is expressed in the rods and the loss of
RdCVF1 in the Xenopus retina leads to cone death could be further tested by
knocking down RdCVF1 in the rods of Xenopus retina without ablating rods to
determine if cones will degenerate. However, there isn’t a good technique that
could be used to turn gene expression on and off in Xenopus laevis later on in
development. Therefore, the best way to determine the effect of RdCVF1
expression on cone viability is to develop double transgenic Xenopus animals
expressing the E. coli nitroreductase enzyme and RdCVF1. This model will
provide an opportunity to treat XOPNTR-RdCVF1 animals with metronidazole to
ablate rods and at the same time see if the over-expression of RdCVF1 will delay
or even inhibit cone death.
In this thesis, I report that RdCVF1 is present in the Xenopus and the
functional domains of the proteins required for its function are conserved. Also,
RdCVF1 is expressed in the Xenopus retina and using the Zuber lab XOPNTR
model; it could be determined whether RdCVF1 can ultimately save cone death.
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Further findings from this project could present a unique therapeutic avenue for
patients suffering from Retinitis Pigmentosa.
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Appendix A

RdCVF1 Amino Acid Sequences
Species
Xenopus laevis
Xenopus Tropicalis
Mouse
Human
Zebrafish
Elephant
Dog
Pig
Cattle
Rhesus monkey
Wild Turkey
Arboreal Lizard
Cichlid fish

GenBank Accession Numbers
NP_001087547
XP_002935469
NP_663573
NP_612463
XP_696316
XP_003413320
XP_541952
XP_003354188
XP_612296
XP_001113624
XP_003213896
XP_003223253
XP_003450058
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Appendix B

Amino Acid Sequences
Species
Xenopus laevis
Xenopus Tropicalis
Mouse
Brown Rat
Human
Cattle
Rabbit
Pike
Guinea Pig
Gibbon
Chimpanzee
Opossum
Arboreal Lizard
Chicken
Zebra Finch
Cichlid Fish

GenBank Accession Numbers
NP_001085382
XP_002937068
NP_083449
NP_001163900
NP_001155097
NP_001179622
XP_002708327
ACO13774
XP_003461886
XP_003279088
XP_520116
XP_001376146
XP_003216546
XP_003643062
XP_002190446
XP_003451530
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Appendix C

RdCVF1 mRNA Sequences
Species
Arboreal Lizard
Cattle
Cichlid Fish
Dog
Elephant
Human
Mouse
Pig
Rhesus Monkey
Wild Turkey
Xenopus laevis
Xenopus Tropicalis
Zebra Fish

GenBank Accession Numbers
XM_003223205
XM_612296
XM_003450010
XM_541952
XM_003413272
NM_138454
NM_145598
XM_003354140
XM_001113624
XM_003213848
NM_001094078
XM_002935423
XM_691224
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Appendix D

RdCVF2 mRNA Sequences
Species
Arboreal Lizard
Brown Rat
Cattle
Chicken
Chimpanzee
Cichlid Fish
Gibbon
Guinea Pig
Human
Mouse
Opossum
Pike
Rabbit
Zebra Finch
Xenopus laevis
Xenopus Tropicalis

GenBank Accession Numbers
XM_003216498
NM_001170429
NM_001192693
XM_003643014
XM_520116
XM_003451482
XM_003279040
XM_003461838
NM_001161625
NM_029173
XM_001376109
BT079350
XM_002708281
XM_002190410
NM_001091913
XM_002937022

Mouse genomic DNA:
NCBIM37:8:74084455:74090548:1
Xenopus laevis Genomic DNA:
Scaffold160012
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Capstone Summary
In the United States alone, more than one million people are blind. One of
the leading causes of blindness is Retinitis Pigmentosa (RP). RP is a group of
inherited disorders that results from the death of photoreceptor cells and leads to
the decline of vision. Approximately 100,000 people in the United States and 1.5
people worldwide are affected by Retinitis Pigmentosa. Currently, there is no
cure.
The human retina is the light sensitive tissue lining the inner surface of the
eye. The retina has many cells including the two types of photoreceptors, rods and
cones. Rods are very sensitive to low light conditions, and are responsible for
vision under low light conditions and also periphery vision. Rods are concentrated
on the outer edges of the retina, and on average there are about 90 million rods in
the retina. On the other hand, cones require more light for functioning, and they
provide information about color in a very sharp detail. Cone cells are concentrated
around the retina’s center. On average there are about 4.5 million cone cells in the
retina. Rod cell death results in night-blindness, leaving daylight vision intact.
Much more devastating to patients is the subsequent death of the cone
photoreceptors. Although cones represent no more than 5% of all photoreceptors
in the human eye, their role in vision is crucial. Cones are required for color
vision, and their death leads to daylight vision loss and ultimately complete
blindness. Uncoupling the cellular and molecular mechanisms that link rod cell
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loss to cone death would allow cones to survive and patients afflicted with
Retinitis Pigmentosa to retain functional vision.
The progressive loss of cones following the initial rapid period of rod
photoreceptor death raises the possibility of rod-cone interactions playing a vital
role in photoreceptor development and survival. Understanding why rod death
leads to cone death is crucial. I hypothesized that rods produce some kind of
signal essential for maintaining cone viability, and the disappearance of rods
deprive cones of this signal and trigger their degeneration. This factor is a protein
known as Rod-derived Cone viability factor 1 (RdCVF1), a protein known to
maintain the function and viability of cone photoreceptor cells in the retina.
Nucleoredoxin like1 (Nxnl1) gene, a protein involved in defense mechanism
against oxidative stress, encodes RdCVF1. In mouse, there is a long form
(RdCVF1-L) and a short form (RdCVF1-S). There is also a similar protein,
RdCVF2, that also has both long and short forms. RdCVF2 expression is not
restricted to the retina but also in the brain, testis, placentas and other tissue types.
However, RdCVF1 is only expressed in the retina and it is the protein I explore in
this project.
In order to explore the importance of RdCVF1 to cone survival in our lab,
we needed a model organism. Our lab chose the tadpoles of the African Clawed
frog, Xenopus laevis, because Xenopus has been used in the field of
developmental biology for long time and wide variety of molecular biology
techniques have been developed for this model organism. Also, many of the genes
have been identified. And it is easy to obtain and maintain large numbers of
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Xenopus tadpoles in the laboratory. Our lab recently developed a model of
Retinitis Pigmentosa in the African Clawed Frog, Xenopus laevis, to examine
whether Xenopus laevis will exhibit the same secondary cellular changes after rod
ablation. To answer this question, Rene Choi generated a transgenic line of
Xenopus laevis, driving the expression of E. coli nitroreductase (NTR) under the
control of the rod-specific rhodopsin promoter (XOP). Nitroreductase converts
nitromidazole prodrugs, such as metronidazole (Mtz), into a cytotoxic DNA cross
linker. Using this drug, we demonstrated that rods were dying during
metronidazole treatment.
Based on the aforementioned observation, I hypothesized that that
RdCVF1 is expressed in the rods of the Xenopus laevis retina. Rod ablation using
our model system results in the loss of RdCVF1, and, as a result, cone
photoreceptors subsequently degenerate and die. If this hypothesis is true, a
Xenopus laevis RdCVF1 ortholog must be present in the Xenopus laevis genome,
and the protein’s functional domains must be conserved in Xenopus and other
species. Also RdCVF1 must be expressed in the rod photoreceptors of the
Xenopus retina.
To determine if a Xenopus laevis RdCVF1 and RdCVF2 ortholog exists, I
used the mouse RdCVF1 and RdCVF2 as a probe, to identify RdCVF1 and
RdCVF2 DNA and protein sequences for homologs in Xenopus and other species.
I found that RdCVF1 and RdCVF2 protein sequences are present in the Xenopus
genome, Xenopus RdCVF1is 60.6% identical to mouse RdCVF1 and Xenopus
RdCVF2 is 65.2% identical to mouse RdCVF2. The proteins’ functional domains

64
such as the “cap” regions and hydrophobic residues are conserved in Xenopus and
other species. The “cap” is a region that is present in the long forms of the
proteins but absent in the short forms. Since there are both RdCVF1 and
RdCVF2, I needed to confirm that the protein I used in the lab was indeed
RdCVF. To do that, I used computer software to generate a phylogenetic tree of
RdCVF1 and RdCVF2 using mRNA sequences. I found that RdCVF1 and
RdCVF2 grouped separately, and the Xenopus laevis RdCVF1 in our lab grouped
with other RdCVF1 sequences, indicating that the protein I used in the lab is most
likely RdCVF1.
After determining that RdCVF1 exists in our model organism, I performed
in situ hybridization to detect the protein expression. In situ hybridization uses a
labeled complementary DNA or RNA strand as a probe to localize a specific
DNA or RNA sequence in a tissue. I used the Xenopus RNA RdCVF1 probe to
find where the protein is expressed the retina. Expression was detected in the
outer nuclear layer of the retina, where rods and cones are located, supporting the
postulation that RdCVF1 is secreted by rods.
In this thesis, I report that RdCVF1 is present in the Xenopus and the
functional domains of the proteins required for its function are conserved. Also,
RdCVF1 is expressed in the Xenopus retina and using the Zuber lab XOPNTR
model; it could be determined whether RdCVF1 can ultimately save cone death.
Further findings from this project could present a unique therapeutic avenue for
patients suffering from Retinitis Pigmentosa.
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